Issue 10/2021
Content (41 Articles)
C. Tinoco Mesquita, M. F. Rezende: Nuclear Cardiology Basic and Advanced Concepts in Clinical Practice
Fiorenzo Squame, Luigi Mansi
Dafang Wu: Clinical Nuclear Medicine Neuroimaging: An Instructional Casebook
Eugenio Di Giorgio, Luigi Mansi
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism
Lavinia Monaco, Cinzia Crivellaro, Massimo Cressoni, Giuseppe Foti, Claudio Landoni, Cristina Messa, Luca Guerra
The importance of lung hyperperfusion patterns in COVID-19-related AVDS
Vincent Jounieaux, Yazine Mahjoub, Isabelle El-Esper, Daniel Oscar Rodenstein
Reply to Paulo Schiavom Duarte
Julian M. M. Rogasch, Carsten Kobe
In memoriam: Marion Hendriks-de Jong
Eric P. Krenning, Gabriel P. Krestin, Monique R. Bernsen, Simone U. Dalm, Otto C. Boerman, Philip H. Elsinga, Andor W. J. M. Glaudemans, Daniëlle J. Vugts, Jolanta Kunikowska, Paola A. Erba, Laura Evangelista, Berthold A. Nock, Theodosia Maina
The approval of a disease-modifying treatment for Alzheimer’s disease: impact and consequences for the nuclear medicine community
Valentina Garibotto, Nathalie L. Albert, Henryk Barthel, Bart van Berckel, Ronald Boellaard, Matthias Brendel, Diego Cecchin, Ozgul Ekmekcioglu, Elsmarieke van de Giessen, Eric Guedj, Adriaan A. Lammerstma, Franck Semah, Tatjana Traub-Weidinger, Donatienne Van Weehaeghe, Silvia Morbelli
First-in-human study of an 18F-labeled boramino acid: a new class of PET tracers
Xiaoli Lan, Kevin Fan, Weibo Cai
Combined use of peptide receptor radionuclide therapy and metronomic chemotherapy in neuroendocrine tumors: a possible choice driven by nuclear medicine molecular imaging
Fabio Minutoli, Riccardo Laudicella, Irene A. Burger, Sergio Baldari
Is it time to include [18F]FDG-PET/CT in the diagnostic work-up for lymph node staging in cN0 vulvar cancer patients?
Nicolas Aide, Stephanie Markovina, Annamaria Ferrero
3D voxel-based dosimetry to predict contralateral hypertrophy and an adequate future liver remnant after lobar radioembolization
Fabiana Grisanti, Elena Prieto, Juan Fernando Bastidas, Lidia Sancho, Pablo Rodrigo, Carmen Beorlegui, Mercedes Iñarrairaegui, José Ignacio Bilbao, Bruno Sangro, Macarena Rodríguez-Fraile
[18F]FMISO PET/CT imaging of hypoxia as a non-invasive biomarker of disease progression and therapy efficacy in a preclinical model of pulmonary fibrosis: comparison with the [18F]FDG PET/CT approach
Julie Tanguy, Françoise Goirand, Alexanne Bouchard, Jame Frenay, Mathieu Moreau, Céline Mothes, Alexandra Oudot, Alex Helbling, Mélanie Guillemin, Philippe Bonniaud, Alexandre Cochet, Bertrand Collin, Pierre-Simon Bellaye
Radiolabelling and preclinical characterization of 89Zr-Df-radiolabelled bispecific anti-PD-L1/TGF-βRII fusion protein bintrafusp alfa
Ingrid Julienne Georgette Burvenich, Yit Wooi Goh, Nancy Guo, Hui Kong Gan, Angela Rigopoulos, Diana Cao, Zhanqi Liu, Uwe Ackermann, Christian Werner Wichmann, Alexander Franklin McDonald, Nhi Huynh, Graeme Joseph O’Keefe, Sylvia Jie Gong, Fiona Elizabeth Scott, Linghui Li, Wanping Geng, Anup Zutshi, Yan Lan, Andrew Mark Scott
Intravital microscopy of tumor vessel morphology and function using a standard fluorescence microscope
Jon-Vidar Gaustad, Trude G. Simonsen, Lise Mari K. Hansem, Einar K. Rofstad
Synthesis and preclinical evaluation of [11C]MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain
Naoyuki Obokata, Chie Seki, Takeshi Hirata, Jun Maeda, Hideki Ishii, Yuji Nagai, Takehiko Matsumura, Misae Takakuwa, Hajime Fukuda, Takafumi Minamimoto, Kazunori Kawamura, Ming-Rong Zhang, Tatsuo Nakajima, Takeaki Saijo, Makoto Higuchi
18F-Boramino acid PET/CT in healthy volunteers and glioma patients
Zhu Li, Ziren Kong, Junyi Chen, Jiyuan Li, Nan Li, Zhi Yang, Yu Wang, Zhibo Liu
First-in-human neuroimaging of soluble epoxide hydrolase using [18F]FNDP PET
Jennifer M. Coughlin, Stephanie Slania, Yong Du, Laura K. Shinehouse, Mary Katherine Brosnan, Babak Behnam Azad, Daniel P. Holt, Hong Fan, Wojciech G. Lesniak, Il Minn, Steven P. Rowe, Robert F. Dannals, Andrew G. Horti, Martin G. Pomper
Synthesis, preclinical evaluation, and a pilot clinical imaging study of [18F]AlF-NOTA-JR11 for neuroendocrine neoplasms compared with [68Ga]Ga-DOTA-TATE
Qing Xie, Teli Liu, Jing Ding, Nina Zhou, Xiangxi Meng, Hua Zhu, Nan Li, Jiangyuan Yu, Zhi Yang
Just another “Clever Hans”? Neural networks and FDG PET-CT to predict the outcome of patients with breast cancer
Manuel Weber, David Kersting, Lale Umutlu, Michael Schäfers, Christoph Rischpler, Wolfgang P. Fendler, Irène Buvat, Ken Herrmann, Robert Seifert
Weakly supervised deep learning for determining the prognostic value of 18F-FDG PET/CT in extranodal natural killer/T cell lymphoma, nasal type
Rui Guo, Xiaobin Hu, Haoming Song, Pengpeng Xu, Haoping Xu, Axel Rominger, Xiaozhu Lin, Bjoern Menze, Biao Li, Kuangyu Shi
Prognostic value of coronary vascular dysfunction assessed by rubidium-82 PET/CT imaging in patients with resistant hypertension without overt coronary artery disease
Valeria Gaudieri, Teresa Mannarino, Emilia Zampella, Roberta Assante, Adriana D’Antonio, Carmela Nappi, Valeria Cantoni, Roberta Green, Mario Petretta, Parthiban Arumugam, Alberto Cuocolo, Wanda Acampa
Spatially constrained kinetic modeling with dual reference tissues improves 18F-flortaucipir PET in studies of Alzheimer disease
Yun Zhou, Shaney Flores, Syahir Mansor, Russ C. Hornbeck, Zhude Tu, Joel S. Perlmutter, Beau Ances, John C. Morris, Robert J. Gropler, Tammie L. S. Benzinger
Long COVID hallmarks on [18F]FDG-PET/CT: a case-control study
Martina Sollini, Silvia Morbelli, Michele Ciccarelli, Maurizio Cecconi, Alessio Aghemo, Paola Morelli, Silvia Chiola, Fabrizia Gelardi, Arturo Chiti
Baseline PET/CT imaging parameters for prediction of treatment outcome in Hodgkin and diffuse large B cell lymphoma: a systematic review
R. Frood, C. Burton, C. Tsoumpas, A. F. Frangi, F. Gleeson, C. Patel, A. Scarsbrook
Equivalent tumor detection for early and late FAPI-46 PET acquisition
J. Ferdinandus, L. Kessler, N. Hirmas, M. Trajkovic-Arsic, R. Hamacher, L. Umutlu, M. Nader, F. Zarrad, M. Weber, W. P. Fendler
A head-to-head comparison of 68Ga-DOTA-FAPI-04 and 18F-FDG PET/MR in patients with nasopharyngeal carcinoma: a prospective study
Chunxia Qin, Fang Liu, Jing Huang, Weiwei Ruan, Qingyao Liu, Yongkang Gai, Fan Hu, Dawei Jiang, Yu Hu, Kunyu Yang, Xiaoli Lan
RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer
Désirée Deandreis, Aline Maillard, Slimane Zerdoud, Claire Bournaud, Lavinia Vija, Christophe Sajous, Marie Terroir, Laurence Leenhardt, Martin Schlumberger, Isabelle Borget, Sophie Leboulleux
18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer
Fengxian Zhang, Xiaodong Wu, Junjie Zhu, Yan Huang, Xiao Song, Lei Jiang
Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors
Silvia Nicolini, Lisa Bodei, Alberto Bongiovanni, Maddalena Sansovini, Ilaria Grassi, Toni Ibrahim, Manuela Monti, Paola Caroli, Anna Sarnelli, Danila Diano, Valentina Di Iorio, Chiara Maria Grana, Corrado Cittanti, Federica Pieri, Stefano Severi, Giovanni Paganelli
18F FDG PET/MRI with hepatocyte-specific contrast agent for M staging of rectal cancer: a primary economic evaluation
Felix G. Gassert, Johannes Rübenthaler, Clemens C. Cyran, Johann S. Rink, Vincent Schwarze, Johanna Luitjens, Florian T. Gassert, Marcus R. Makowski, Stefan O. Schoenberg, Marius E. Mayerhoefer, Dietmar Tamandl, Matthias F. Froelich
Phase I study to assess safety, biodistribution and radiation dosimetry for 89Zr-girentuximab in patients with renal cell carcinoma
Robin I. J. Merkx, Daphne Lobeek, Mark Konijnenberg, Luis David Jiménez-Franco, Andreas Kluge, Egbert Oosterwijk, Peter F.A. Mulders, Mark Rijpkema
EANM guideline on the role of 2-[18F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA)
Roberto C. Delgado Bolton, Nicolas Aide, Patrick M. Colletti, Annamaria Ferrero, Diana Paez, Andrea Skanjeti, Francesco Giammarile
Diagnostic performance of preoperative [18F]FDG-PET/CT for lymph node staging in vulvar cancer: a large single-centre study
Vittoria Rufini, Giorgia Garganese, Francesco P. Ieria, Tina Pasciuto, Simona M. Fragomeni, Benedetta Gui, Anita Florit, Frediano Inzani, Gian Franco Zannoni, Giovanni Scambia, Alessandro Giordano, Angela Collarino
Diagnostic performance of 68Ga-PSMA-11 PET/MRI-guided biopsy in patients with suspected prostate cancer: a prospective single-center study
Daniela A. Ferraro, Anton S. Becker, Benedikt Kranzbühler, Iliana Mebert, Anka Baltensperger, Konstantinos G. Zeimpekis, Hannes Grünig, Michael Messerli, Niels J. Rupp, Jan H. Rueschoff, Ashkan Mortezavi, Olivio F. Donati, Marcelo T. Sapienza, Daniel Eberli, Irene A. Burger
Early alkaline phosphatase dynamics as biomarker of survival in metastatic castration-resistant prostate cancer patients treated with radium-223
Maarten J. van der Doelen, Agnes Stockhaus, Yuanjun Ma, Niven Mehra, Jeffrey Yachnin, Winald R. Gerritsen, Sten Nilsson, Inge M. van Oort, Anders Ullén
Complicated pubovesical fistula on PET/CT and MRI
Omer Aras, Haluk B Sayman
[68Ga]Ga-PSMA-HBED-CC PET/CT demonstrates to be superior to ceCT in detecting early treatment response in metastatic clear cell renal cell carcinoma
Priscilla Guglielmo, Donatello Gasparro, Maura Scarlattei, Giorgio Baldari, Stefano Bola, Silvia Migliari, Antonino Sammartano, Umberto Maestroni, Livia Ruffini
Pulmonary tumor thrombotic microangiopathy: the role of a lung perfusion SPECT-CT study
Stefanelli Antonella, Guarneri Andrea, Savelli Giordano, Bonacina Mattia, Zaniboni Alberto
Deepening of response to prostate-specific membrane antigen ligand-targeted radioligand therapy beyond end of treatment
Thorsten Derlin, Elke Krischke, Tobias L. Ross, Frank M. Bengel